Copycat Ozempic, Mounjaro proliferate even in postshortage era
BY JOSEPH CHOI - 08/19/25 6:00 AM ET
Copycat versions of popular drugs like Ozempic and Mounjaro have continued to proliferate in a postshortage era, with some experts saying “regulatory neglect” is allowing for potentially dangerous, unapproved drugs to reach consumers.
Read more via The Hill:
https://thehill.com/policy/healthcare/5457899-compounded-glp-1s-online-sales/